Proposed Collection; 60-Day Comment Request; NIH COVID-19 Vaccination Status Form Extension, 66319-66320 [2021-25412]
Download as PDF
<![CDATA[
66319
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
if finalized, would replace the Deemed
Final Order in its entirety with new
conditions under which
nonprescription sunscreen drug
products would be determined to be
GRASE under section 201(p)(1) of the
FD&C Act (21 U.S.C. 321(p)(1)). It would
also set forth certain characteristics
establishing that a sunscreen drug
product is not GRASE under section
201(p)(1) of the FD&C Act.
The original close of the public
comment period for this Proposed Order
was November 12, 2021. On November
2, 2021, the Agency received a request
to extend this comment period by a
minimum of 45 days, conveying
concern that the original comment
period did not provide sufficient time
for review of the Proposed Order or for
submission of needed updates related to
sunscreen active ingredients about
which FDA had requested additional
data. FDA considered the request and
extended the public comment period for
the Proposed Order for an additional 45
days, until December 27, 2021.2 This
extension will allow additional time for
the public to submit information related
to these active ingredients (and other
proposed sunscreen conditions) that has
become available since the closure of
the comment period on the 2019
Proposed Rule ‘‘Sunscreen Drug
Products for Over-the-Counter Human
Use’’ (2019 Proposed Rule).
The Agency reiterates that, as stated
in the notice of availability of the
Proposed Order published in the
Federal Register on September 27, 2021,
and in the Proposed Order itself, the
Agency will consider all comments that
were submitted to the public docket for
the 2019 Proposed Rule within its
comment period to be constructively
submitted as comments on the Proposed
Order. The Agency requests that
commenters do not resubmit comments
on this Proposed Order previously
submitted on the 2019 Proposed Rule.
Dated: November 16, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021–25371 Filed 11–19–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jspears on DSK121TN23PROD with NOTICES1
[Document Identifier: OS–0990–0475]
Agency Information Collection
Request. 30-Day Public Comment
Request
AGENCY:
Office of the Secretary, HHS.
2 See https://www.regulations.gov/document/
FDA-1978-N-0018-15828.
VerDate Sep<11>2014
18:30 Nov 19, 2021
Jkt 256001
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before December 22,
2021.
SUMMARY:
Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–0475, and
project title for reference, to Sherrette
Funn, the Reports Clearance Officer,
Sherrette.funn@hhs.gov, or call 202–
795–7714.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: ASPA COVID–
19 Public Education Campaign
Evaluation Surveys.
Type of Collection: Extension.
OMB No.: 0990–0475.
Abstract: The Office of the Assistant
Secretary for Public Affairs (ASPA), U.S.
Department of Health and Human
Services (HHS) is requesting an
extension on a currently approved
collection including two components: 1.
COVID–19 Attitudes and Beliefs Survey
(CABS), and 2. Monthly Outcome
Survey (MOS). Throughout execution of
the campaign, this information will
primarily be used by ASPA to determine
whether the campaign is having the
intended impact on target audiences’
(e.g., parents, young adults, 65+)
knowledge, attitudes, and beliefs as they
relate to COVID–19, COVID–19
vaccination, and adherence to
preventative behaviors. It will also keep
key stakeholders informed of the
Campaign’s progress. Ultimately, the
data will inform a thorough evaluation
of the efficacy of the campaign and its
impact on vaccine uptake.
ADDRESSES:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
COVID–19 Attitudes and Beliefs Survey
(CABS)
The CABS is a longitudinal survey
that will be fielded tri-annually to 4,000
U.S. adults for the duration of the
Campaign via NORC at the University of
Chicago’s AmeriSpeak Panel. The
survey will be fielded online, and each
fielding period will last between 3 and
6 weeks. Those that respond to wave 1
of the survey will be recontacted in each
wave, facilitating a comparison of
COVID–19 behavior change over time
for a representative sample and
evaluation of U.S. adults. Panel
members selected to participate in the
study will receive one pre-invitation
postcard in the mail, one email
invitation, and three email reminders to
complete the survey in each wave.
Monthly Outcome Survey (MOS)
The MOS is a shorter, cross-sectional
survey that will be fielded monthly to
5,000 U.S. adults for the duration of the
Campaign via the Ipsos KnowledgePanel
5K Omnibus Survey. The survey will be
fielded online, and each fielding period
will last between 7 and 10 days.
ANNUALIZED BURDEN HOUR TABLE
CABS
Hours to complete
survey ....................
Participants (per
wave) .....................
Number of waves
(per year) ..............
Total respondents per
year .......................
Total burden hours
per year .................
MOS
0.58
0.17
4,000
5,000
3
12
12,000
60,000
6,960
10,200
Sum of Both Studies
Total respondents per year: 72,000.
Total burden hours per year: 17,160.
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–25370 Filed 11–19–21; 8:45 am]
BILLING CODE 4150–25–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; NIH COVID–19 Vaccination
Status Form Extension
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
SUMMARY:
E:\FR\FM\22NON1.SGM
22NON1
66320
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health (NIH),
Office of Research Services (ORS),
Division of Occupational Health and
Safety (DOHS) will publish periodic
summaries of proposed projects to be
submitted to the Office of Management
and Budget (OMB) for review and
approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Jessica McCormick-Ell,
Ph.D., SM (NRCM), CBSP, RBP, NIH/
ORS/SR/DOHS, Bldg. 13/3W80,
Bethesda, MD 20892–5760 or call nontoll-free number (301) 496–0590 or
Email your request, including your
address to: jessica.mccormick-ell@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimizes
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title: NIH
COVID–19 Vaccination Status Form
EXTENSION, 0925–0771, exp., 3/31/
2022, Office of Research Services (ORS),
National Institutes of Health (NIH).
SUPPLEMENTARY INFORMATION:
Need and Use of Information
Collection: The purpose of the NIH
COVID–19 Vaccination Status Form is
to ensure the safety of the Federal
workplace consistent with Executive
Order 14042 Ensuring Adequate COVID
Safety Protocols for Federal Contractors,
Executive Order 14043 Requiring
Coronavirus Disease 2019 Vaccination
for Federal Employees, the COVID–19
Workplace Safety: Agency Model Safety
Principles established by the Safer
Federal Workforce Task Force, and
guidance from the Centers for Disease
Control and Prevention (CDC) and the
Occupational Safety and Health
Administration (OSHA). The proposed
information collection will be used to
ensure compliance with vaccination
requirements in the authorities above,
generate the list of persons required to
be tested on a routine basis, and will
provide important information
regarding safety frameworks, guidance,
and procedures.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2,583.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Average time
per response
(in hours)
Total annual
burden hour
Certified nurse coaches .................................................................................
31,000
1
5/60
2,583
Total ........................................................................................................
........................
31,000
........................
2,583
Dated: November 16, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2021–25412 Filed 11–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
jspears on DSK121TN23PROD with NOTICES1
Number of
responses per
respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
18:30 Nov 19, 2021
Jkt 256001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Computational, Modeling, and
Biodata Management.
Date: December 3, 2021.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marie-Jose Belanger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 6188,
MSC 7804, Bethesda, MD 20892, (301) 435–
1267, belangerm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
Dated: November 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
[FR Doc. 2021–25386 Filed 11–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 86, Number 222 (Monday, November 22, 2021)]
[Notices]
[Pages 66319-66320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25412]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; NIH COVID-19
Vaccination Status Form Extension
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork
[[Page 66320]]
Reduction Act of 1995 to provide opportunity for public comment on
proposed data collection projects, the National Institutes of Health
(NIH), Office of Research Services (ORS), Division of Occupational
Health and Safety (DOHS) will publish periodic summaries of proposed
projects to be submitted to the Office of Management and Budget (OMB)
for review and approval.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: Dr. Jessica
McCormick-Ell, Ph.D., SM (NRCM), CBSP, RBP, NIH/ORS/SR/DOHS, Bldg. 13/
3W80, Bethesda, MD 20892-5760 or call non-toll-free number (301) 496-
0590 or Email your request, including your address to:
[email protected]. Formal requests for additional plans and
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written comments and/or suggestions
from the public and affected agencies are invited to address one or
more of the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) Ways
to minimizes the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Proposed Collection Title: NIH COVID-19 Vaccination Status Form
EXTENSION, 0925-0771, exp., 3/31/2022, Office of Research Services
(ORS), National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of the NIH
COVID-19 Vaccination Status Form is to ensure the safety of the Federal
workplace consistent with Executive Order 14042 Ensuring Adequate COVID
Safety Protocols for Federal Contractors, Executive Order 14043
Requiring Coronavirus Disease 2019 Vaccination for Federal Employees,
the COVID-19 Workplace Safety: Agency Model Safety Principles
established by the Safer Federal Workforce Task Force, and guidance
from the Centers for Disease Control and Prevention (CDC) and the
Occupational Safety and Health Administration (OSHA). The proposed
information collection will be used to ensure compliance with
vaccination requirements in the authorities above, generate the list of
persons required to be tested on a routine basis, and will provide
important information regarding safety frameworks, guidance, and
procedures.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 2,583.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Certified nurse coaches........................ 31,000 1 5/60 2,583
----------------------------------------------------------------
Total...................................... .............. 31,000 .............. 2,583
----------------------------------------------------------------------------------------------------------------
Dated: November 16, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-25412 Filed 11-19-21; 8:45 am]
BILLING CODE 4140-01-P
